These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 8959903)
1. Toxic pustuloderma associated with clemastine therapy. Feind-Koopmans A; Van der Valk PG; Steijlen PM; Van de Kerkhof PC Clin Exp Dermatol; 1996 Jul; 21(4):293-5. PubMed ID: 8959903 [TBL] [Abstract][Full Text] [Related]
2. Multilocalized fixed drug eruption to the antihistamine cetirizine. Kränke B; Kern T J Allergy Clin Immunol; 2000 Nov; 106(5):988. PubMed ID: 11080726 [No Abstract] [Full Text] [Related]
3. [Remove Tavegyl]. Gottberg L Lakartidningen; 2012 Aug 22-Sep 4; 109(34-35):1483-4. PubMed ID: 22993901 [No Abstract] [Full Text] [Related]
4. Toxic pustuloderma--a new entity? Staughton RC; Payne CM; Harper JI; McMichen H J R Soc Med; 1984; 77 Suppl 4(Suppl 4):6-8. PubMed ID: 6239924 [No Abstract] [Full Text] [Related]
5. Comparative study of the efficacy and tolerance of terfenadine and clemastine in patients with seasonal allergic rhinitis. Gastpar H; Dieterich HA Arzneimittelforschung; 1982; 32(9a):1211-3. PubMed ID: 6129872 [TBL] [Abstract][Full Text] [Related]
6. Tremor after ingestion of Tazist-D and Tylenol 3. Egsieker E; Mullins ME; Naunheim R Am J Emerg Med; 2000 Sep; 18(5):638. PubMed ID: 10999588 [No Abstract] [Full Text] [Related]
7. Neuropsychologic and cardiovascular effects of clemastine fumarate under pressure. Sipinen SA; Kulvik M; Leiniö M; Viljanen A; Lindholm H Undersea Hyperb Med; 1995 Dec; 22(4):401-6. PubMed ID: 8574128 [TBL] [Abstract][Full Text] [Related]
8. Comparative two-phase clinicopharmacological trial of a new antihistaminic, EGYT-2062, setastine. Vezekényi Z; Zolnai K; Nagy L Acta Med Hung; 1987; 44(1):55-64. PubMed ID: 2890137 [TBL] [Abstract][Full Text] [Related]
13. Pustuloderma during cutaneous lupus treatment with thalidomide. Rúa-Figueroa I; Erausquin C; Naranjo A; Carretero-Hernández G; Rodriguez-Lozano C; De la Rosa P Lupus; 1999; 8(3):248-9. PubMed ID: 10342720 [No Abstract] [Full Text] [Related]
14. Fixed drug eruption caused by dimenhydrinate. Saenz de San Pedro B; Quiralte J; Florido JF Allergy; 2000 Mar; 55(3):297. PubMed ID: 10753024 [No Abstract] [Full Text] [Related]
15. Fixed drug eruption due to loratadine. Ruiz-Genao DP; Hernández-Nüñez A; Sánchez-Pérez J; García-Díez A Br J Dermatol; 2002 Mar; 146(3):528-9. PubMed ID: 11952560 [No Abstract] [Full Text] [Related]
16. Inhibition of mast cell degranulation-induced drop of blood pressure with clemastine, cromolyn and compound 48/80 pretreatment. Peternel L; Cerne M; Drevensek G; Stempelj M; Urleb U; Stanovnik L; Budihna MV Inflamm Res; 2006 Apr; 55 Suppl 1():S07-8. PubMed ID: 16705372 [No Abstract] [Full Text] [Related]
17. [Fixed pigmented erythema antihistamine H1: about 2 cases and review of the literature]. Lakhoua G; El Aidli S; Zaïem A; Sahnoun R; Kastalli S; Hedi Loueslati M; Daghfous R Therapie; 2014; 69(3):243-4. PubMed ID: 24934820 [TBL] [Abstract][Full Text] [Related]
18. Hypertensive crisis secondary to phenylpropanolamine interacting with triple-drug therapy for HIV prophylaxis. Khurana V; de la Fuente M; Bradley TP Am J Med; 1999 Jan; 106(1):118-9. PubMed ID: 10320127 [No Abstract] [Full Text] [Related]